Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Qwerty54321


T.TH

RE:Further clarity needed & size of mkt.

I thought the efficacy data was vague, not in typical 'RECIST language...

12 days ago

T.TH

RE:RE:RE:Good deal or not?

I guess there are competing forces at play here. There is no treatment atm...

December 6, 2024

T.TH

RE:Good deal or not?

Seems to be a lot about 'founder effect' in Quebec for FCS. ...

December 5, 2024

T.TH

RE:Murky sales report imo

That's how I read it. Drawn to exactly the same sentence. palinc2000...

July 10, 2024

V.FL

RE:RE:TBT News

Comments on change.org petition website read like typical wokesters with...

June 28, 2024

V.RHT.H

RE:RE:Poorly run company is afraid of this

If there's no substance it wouldn't matter if this was run by a bunch...

June 26, 2024

T.TH

RE:Summary of published results to date

They wouldn't be tinkering with the dose if the toxicity was fine. And if...

June 22, 2024

V.RHT.H

RE:RE:RE:RE: Need a new CEO

....... or only 1 in 20 of your "adherent" patients give you the...

June 20, 2024

V.RHT.H

RE:RE:RE:video interview

JMO, I doubt at this point adherence=revenue generator. It doesn't seem...

June 11, 2024

T.TH

RE:Progression free survival rate

I get ur point but you have to look at what other lung cancer drugs are...

June 1, 2024

T.TH

RE:ASCO Info

One thing the AI didn't pick up is the analysis is for a SUBSET of all...

May 27, 2024

T.TH

RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Certainly stable disease is a great thing for individual patients but it is...

May 24, 2024

T.TH

RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Analias, I don't really think these result are a strong indicator of...

May 24, 2024

T.TH

RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

So my initial thoughts revolve around the MOA too. Both positive and negative...

May 24, 2024

V.RHT.H

RE:RE:RE:New Press Release - Reliq Health Technologies, Inc. Announces Expansion of Contract with a Large US Healthcare Group to add over 30,000 New Patients to iUGO Care

This is supposedly how this industry operates. Test it out on a limit cohort,...

May 17, 2024

V.RHT.H

RE:RE:New Press Release - Reliq Health Technologies, Inc. Announces Expansion of Contract with a Large US Healthcare Group to add over 30,000 New Patients to iUGO Care

Just to remind you we are all mortal so "indefinitely" shouldn'...

May 17, 2024

V.RHT.H

RE:RE:Proposed changes to RPM billing rules

Horses for courses. My father would be great at this because he does...

May 7, 2024

V.RHT.H

RE:Maxim report June 2023

The patients buy from Reliq on monthly payment schemes. Do you know Reliq...

May 6, 2024

V.RHT.H

RE:RE:Patient Copay

This sounds bleak. https://www.chartspan.com/blog/why-remote-patient...

May 3, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:POC in humans has been acheived is that it

I would really caution that this is them just doing what responsible trial...

May 3, 2024

1 2 3 4 5 Next

Featured Company